Eli Lilly tries to stop GLP-1 copycats
Eli Lilly said it filed six lawsuits against US companies it accused of selling illicit versions of its experimental obesity drug retatrutide.
We haven't written up this one. Semafor has the full story — the link below goes straight to it.